Cargando…
Gene-Guided Treatment Decision-Making in Non-Small Cell Lung Cancer – A Systematic Review
Decision-making in cancer treatment is part of clinicians’ everyday work, and it is especially challenging in non-small cell lung cancer (NSCLC) patients, for whom decisions are clearly dependent on gene alterations or the lack of them. The multimodality of treatments, involvement of gene alteration...
Autores principales: | Saarenheimo, Jatta, Andersen, Heidi, Eigeliene, Natalja, Jekunen, Antti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546351/ https://www.ncbi.nlm.nih.gov/pubmed/34712614 http://dx.doi.org/10.3389/fonc.2021.754427 |
Ejemplares similares
-
The Value of Liquid Biopsies for Guiding Therapy Decisions in Non-small Cell Lung Cancer
por: Saarenheimo, Jatta, et al.
Publicado: (2019) -
Current challenges in applying gene-driven therapies in clinical lung cancer practice
por: Saarenheimo, Jatta, et al.
Publicado: (2021) -
Metastatic Rectal Carcinoma with Long-Term Remission due to Modern Multimodality Treatment
por: Eigeliene, Natalja, et al.
Publicado: (2021) -
Radiotherapy treatment modification for prostate cancer patients based on PSMA-PET/CT
por: Karagiannis, Vasileios, et al.
Publicado: (2022) -
Decision-making in product portfolios of pharmaceutical research and development – managing streams of innovation in highly regulated markets
por: Jekunen, Antti
Publicado: (2014)